|
Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The Cellomics platform includes automated imaging instrumentation (ArrayScan® and KineticScan® HCS Readers), BioApplication image analysis software, High Content Informatics (HCi™), and HitKit® HCS Reagent Kits, fully integrated to improve the quality and productivity of cell-based assays. Cellomics’ proprietary platforms are in use at multiple sites within the top 15 pharmaceutical companies, as well as leading biotechnology companies and academic centers throughout the world. Corporate Facts:
- Pittsburgh, PA based company, founded in 1996, a business unit within the Fisher Biosciences group.
- State-of-art facility integrating research, development, manufacturing, and training
- Core expertise in:
- Quantitative Fluorescence Microscopy
- Cell Biology
- Molecular Biology
- Drug Discovery and Pharmacology
- Engineering
- Applied Optics and physics
- Database Design and Data Mining
- Inventor of High Content Screening and Market Leader in delivering platform solutions
- Cellomics technology in use at top 15 pharma companies
- World wide placement in pharma, biopharma, and biotech
- 4 academic centers with Cellomics technologies established
- Many multiple unit users
Worldwide Corporate Headquarters: Cellomics Inc. 100 Technology Drive Pittsburgh, PA, 15219 USA Phone: 412-770-2200 Fax: 412-770-2450
European Corporate Headquarters: Cellomics - Europe Wyvols Court Swallowfield Reading Berkshire RG7 1WY United Kingdom Phone: + 44 118 988 0262 Fax: + 44 118 988 0362
|